MedWatch

Astrazeneca on vaccine skepticism: "Many forget it's a non-profit project"

The fact that many countries around the world are pausing the vaccine from Astrazeneca has no financial consequences for the pharmaceutical giant, according to the country director of Denmark and Norway. However, he does not rule out that the vaccine might suddenly be turned into a lucrative business.

Astrazeneca Country Director ( Managing Director) Denmark and Norway Christof Bischoff | Photo: Astrazeneca/PR/Ulrike Schacht

The Covid-19 vaccine from Astrazeneca has taken some hits since last week, when the European Medicines Agency (EMA) confirmed that the EMA's safety experts sees a possible connection between this vaccine and a series of rare but highly serious, and sometimes fatal, side effects.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs